I-125 seed brachytherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for I-125 seed brachytherapy, covering 2022-11-08 to 2022-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC [Phase 3]